Skip to main content
OpenTrials
Completed

NCT Number: NCT05240378

Mortality of Cancer Surgery During SARS CoV2 Pandemic

The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS CoV 2 Infection COVID-19 Cancer Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Neoplasms Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Banaras Hindu University

Varanasi, Uttar Pradesh, 221005, India

About this study

This is a retrospective study from the prospectively collected data that is extracted from the electronic database of Department of Surgical Oncology, IMS, BHU The data is inform of two cohorts one extending from April 2019-April 2020 and other from May 2020 to May 2021 i.e. pre covid and during covid pandemic

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients operated during the study period

Exclusion criteria

  • None

Treatment and study plan

SURGERY

Other

Surgery for cancer as per the stage of the disease and protocol

Primary outcomes

  1. 30 day mortality

    Time frame: 30 days

    post operative deaths within one year

  2. number of participants developing major or minor complications

    Time frame: 30 days

    Surgical complications classified as per Clavien Dindo classification

Secondary outcomes

  1. number of health care worker with SARS CoV2 infection

    Time frame: 1 year

    Covid infection in health care workers

Sponsors and collaborators

Lead sponsor

Banaras Hindu University

Other

Registry information

Official study title

Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Feb 15, 2022
Registry last updated
Mar 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.